Eupraxia Pharmaceuticals Inc (EPRX) Live Share Price, Invest From India

Eupraxia Pharmaceuticals Inc Stock Performance

as on January 31, 2026 at 2:29 am IST

Day's Low
Day's High
$8.04
Day's Price Range
$8.47
$8.27
2.78%
Downside
2.42%
Upside
52 Week's Low
52 Week's High
$2.68
52-Week Price Range
$9.32
$8.27
67.59%
Downside
12.70%
Upside

Eupraxia Pharmaceuticals Inc share price movements today

Previous Close: $8.35
Open: $8.35
Volume: 762.8K
Day's Low - High: $8.04 - $8.47
52 Week Low - High: $2.68 - $9.32

Eupraxia Pharmaceuticals Inc Historical Returns

1 Month Return: + 9.67 %
3 Month Return: + 49.46 %
1 Year Return: + 185.94 %
3 Year Return: 0 %
5 Year Return: 0 %

Eupraxia Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Eupraxia Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$439.1M

EPS (TTM)

-0.714

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-29.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-61.02%

Eupraxia Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eupraxia Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eupraxia Pharmaceuticals Inc	BUY	$439.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	124.65%	1246.03	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	105.12%	33.56	31.35%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	47.16%	18.28	32.13%

Stock Returns calculator for Eupraxia Pharmaceuticals Inc Stock including INR - Dollar returns

The Eupraxia Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Eupraxia Pharmaceuticals Inc investment value today

Current value as on today

₹2,91,333

Returns

₹1,91,333

(+191.33%)

Returns from Eupraxia Pharmaceuticals Inc Stock

₹1,85,172 (+185.17%)

Dollar Returns*

₹6,161 (+6.16%)

Analyst Recommendation on Eupraxia Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Eupraxia Pharmaceuticals Inc. Average target price of $14.4

Eupraxia Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Eupraxia Pharmaceuticals Inc.

What analysts predicted

42.57%UPSIDE

Target Price

$14.4

Current Price

$8.27

Analyzed by

8 Analysts

Target

$14.40

Eupraxia Pharmaceuticals Inc target price $14.4, a slight upside of 42.57% compared to current price of $8.27. According to 8 analysts rating.

Eupraxia Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Eupraxia Pharmaceuticals Inc Stock has increased by 275% in the last 30 days, reflecting an upward trend in search activity.

Time period: January 1, 2026 to January 31, 2026

Change:275% versus previous 30 day period

Eupraxia Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	2	2	-	-	-	-	-	-
Gross Profit	0	0	1	1	0	-	-	-	-	-
Operating Income	-5	-8	-6	-6	-8	-8	-10	-10	-11	-9
EBITDA	-9	-4	-4	-5	-7	-8	-10	-9	-11	-8
Interest Expense	0	0	0	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-4	-4	-6	-8	-8	-10	-9	-11	-8
Income Tax Expense	0	0	0	0	0	-	0	0	0	0
Net Income	-7	-3	-3	-4	-8	-8	-10	-9	-11	-8
Net Profit Margin	0.00%	0.00%	-158.49%	-202.86%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Eupraxia Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	-
Operating Income	-2	-14	-17	-27	-38
EBITDA	-2	-17	-17	-27	-35
Interest Expense	1	1	0	1	0
Depreciation	0	0	0	0	0
Income Before Tax	-4	-18	-18	-28	-37
Income Tax Expense	1	-1	0	0	0
Net Income	-4	-18	-18	-28	-36
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Eupraxia Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-4	-4	-6	-6	-5	-7	-6	-8	-6
Operating Cash Flow	-5	0	-6	-7	-10	-5	-6	-8	-4
Investing Cash Flow	0	-	0	0	0	0	0	0	0
Financing Cash Flow	16	-7	23	-4	-4	31	0	0	73
Change in Cash	10	-13	16	-12	-14	24	-5	-7	69

Eupraxia Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-14	-7	-3	-18	-18	-28	-25
Operating Cash Flow	-8	-5	0	-11	-14	-20	-29
Investing Cash Flow	0	-1	0	-11	9	0	0
Financing Cash Flow	5	7	0	39	10	21	45
Change in Cash	-3	0	-1	16	5	1	13

Insights on Eupraxia Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, EPRX stock has moved up by 49.5%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, EPRX has outperformed top 5 stocks with highest market-cap in its industry

About Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release alternatives to approved drugs. The Company’s principal business is the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidate, EP-104IAR, is designed to meet the unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis (OA). The primary active ingredient of the EP-104 products consists of a solid core of fluticasone propionate (FP) coated with an outer layer of polyvinyl alcohol (PVA). Its lead product candidate is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms and is used corticosteroid with systemic safety record. EP-104 is in Phase Ib/IIa clinical development.

Organisation	Eupraxia Pharmaceuticals Inc
Headquarters	2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
CEO	Dr. James A. Helliwell FRCPC, M.D.
E-voting on shares	Click here to vote

Key Management of Eupraxia Pharmaceuticals Inc

Name	Title
Mr. Alexander John Rothwell Eng., M.B.A.	Chief Financial Officer
Mr. Alex Therien	Executive VP, R&D
Dr. James A. Helliwell FRCPC, M.D.	CEO & Director
Dr. Amanda Malone Ph.D.	Chief Scientific Officer & COO
Mr. Paul Anthony Brennan B.Sc., M.Sc.	Chief Business Officer
Dr. Mark M. Kowalski M.D., Ph.D.	Chief Medical Officer

FAQs

What is Eupraxia Pharmaceuticals Inc share price today?

Eupraxia Pharmaceuticals Inc share price today is $8.27 as on January 31, 2026 at 2:29 am IST at the close of the market. Eupraxia Pharmaceuticals Inc share today touched a day high of $8.47 and a low of $8.04.

What is the 52 week high and 52 week low for Eupraxia Pharmaceuticals Inc share?

Eupraxia Pharmaceuticals Inc share touched a 52 week high of $9.32 on January 21, 2026 and a 52 week low of $2.68 on April 7, 2025. Eupraxia Pharmaceuticals Inc stock price today i.e. January 31, 2026 at 2:29 am IST is closed at $8.27,which is 11.27% down from its 52 week high and 208.57% up from its 52 week low.

What is Eupraxia Pharmaceuticals Inc's market capitalisation today?

Eupraxia Pharmaceuticals Inc market capitalisation is $0.00T as on January 31, 2026 at 2:29 am IST.

How to invest in Eupraxia Pharmaceuticals Inc Stock (EPRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eupraxia Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eupraxia Pharmaceuticals Inc Shares that will get you 0.1814 shares as per Eupraxia Pharmaceuticals Inc share price of $8.27 per share as on January 31, 2026 at 2:29 am IST.

What is the minimum amount required to buy Eupraxia Pharmaceuticals Inc Stock (EPRX) from India?

Indian investors can start investing in Eupraxia Pharmaceuticals Inc (EPRX) shares with as little as ₹91.906 or $1 (as of January 31, 2026 at 3:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹919.06 in Eupraxia Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on January 31, 2026 at 3:42 pm IST). Based on Eupraxia Pharmaceuticals Inc share’s latest price of $8.27 as on January 31, 2026 at 2:29 am IST, you will get 1.2092 shares of Eupraxia Pharmaceuticals Inc. Learn more about fractional shares .